| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.NEUROPHARM.2011.02.003 |
| P8608 | Fatcat ID | release_ok3fud4c4zgq3bcnrs6yz3skua |
| P932 | PMC publication ID | 3115479 |
| P698 | PubMed publication ID | 21315744 |
| P5875 | ResearchGate publication ID | 49830895 |
| P50 | author | Jun Nomura | Q51946215 |
| P2093 | author name string | Chunxia Yang | |
| Irina N Krasnova | |||
| Jean Lud Cadet | |||
| Vladimir M Pogorelov | |||
| Atsushi Kamiya | |||
| Yu Taniguchi | |||
| Mikhail V Pletnikov | |||
| Yavuz Ayhan | |||
| Dean F Wong | |||
| Geetha Kannan | |||
| Jongho Kim | |||
| Bagrat Abazyan | |||
| Heather Valentine | |||
| P2860 | cites work | The DISC1 pathway modulates expression of neurodevelopmental, synaptogenic and sensory perception genes | Q21092132 |
| SH3 binding domains in the dopamine D4 receptor | Q22008481 | ||
| DISC1 regulates primary cilia that display specific dopamine receptors | Q24318393 | ||
| Disrupted in schizophrenia 1 regulates neuronal progenitor proliferation via modulation of GSK3beta/beta-catenin signaling | Q24322974 | ||
| Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine | Q28235275 | ||
| The DISC locus in psychiatric illness | Q28251868 | ||
| The genetics and biology of DISC1--an emerging role in psychosis and cognition | Q28252172 | ||
| A frameshift mutation in Disrupted in Schizophrenia 1 in an American family with schizophrenia and schizoaffective disorder | Q28254976 | ||
| Behavioral despair in mice: a primary screening test for antidepressants | Q28258027 | ||
| DISC1 and PDE4B are interacting genetic factors in schizophrenia that regulate cAMP signaling | Q28282412 | ||
| A neurobiological basis for substance abuse comorbidity in schizophrenia | Q28347063 | ||
| DISC1 regulates new neuron development in the adult brain via modulation of AKT-mTOR signaling through KIAA1212 | Q28513802 | ||
| Preferential Interaction between the dopamine D2 receptor and Arrestin2 in neostriatal neurons | Q28575887 | ||
| Disrupted-in-Schizophrenia 1 (DISC1) regulates spines of the glutamate synapse via Rac1 | Q28583457 | ||
| Knockdown of DISC1 by in utero gene transfer disturbs postnatal dopaminergic maturation in the frontal cortex and leads to adult behavioral deficits | Q30475728 | ||
| Behavioral genetic contributions to the study of addiction-related amphetamine effects | Q30494693 | ||
| Dual constraints on synapse formation and regression in schizophrenia: neuregulin, neuroligin, dysbindin, DISC1, MuSK and agrin | Q31162413 | ||
| Comorbidity of substance abuse with other psychiatric disorders | Q33285122 | ||
| Genes and molecules that can potentiate or attenuate psychostimulant dependence: relevance of data from animal models to human addiction | Q33383358 | ||
| Childhood onset schizophrenia: support for a progressive neurodevelopmental disorder | Q33721607 | ||
| Brain maturational processes and delayed onset in schizophrenia. | Q33758185 | ||
| A form of DISC1 enriched in nucleus: altered subcellular distribution in orbitofrontal cortex in psychosis and substance/alcohol abuse. | Q33762395 | ||
| Cortical-striatal integration of cocaine history and prefrontal dysfunction in animal modeling of dual diagnosis | Q33770817 | ||
| Schizophrenia: genes and environment | Q33842577 | ||
| Chromosomal location and genomic structure of the human translin-associated factor X gene (TRAX; TSNAX) revealed by intergenic splicing to DISC1, a gene disrupted by a translocation segregating with schizophrenia. | Q33914120 | ||
| The addicted synapse: mechanisms of synaptic and structural plasticity in nucleus accumbens. | Q33940362 | ||
| Behavioral and morphological responses to cocaine require kalirin7. | Q34009298 | ||
| Kalirin-7, an important component of excitatory synapses, is regulated by estradiol in hippocampal neurons | Q34026137 | ||
| Differential effects of prenatal and postnatal expressions of mutant human DISC1 on neurobehavioral phenotypes in transgenic mice: evidence for neurodevelopmental origin of major psychiatric disorders. | Q34039895 | ||
| Substance abuse in schizophrenia: a review of the literature and a study of correlates in Sweden | Q34201663 | ||
| The functional divide for primary reinforcement of D-amphetamine lies between the medial and lateral ventral striatum: is the division of the accumbens core, shell, and olfactory tubercle valid? | Q34333767 | ||
| Activation of orbital and medial prefrontal cortex by methylphenidate in cocaine-addicted subjects but not in controls: relevance to addiction. | Q34411360 | ||
| Dendritic spine dynamics--a key role for kalirin-7. | Q34791771 | ||
| The need for speed: an update on methamphetamine addiction | Q35012661 | ||
| Serious mental illness and tobacco addiction: a model program to address this common but neglected issue | Q35559018 | ||
| Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement | Q35844174 | ||
| A review of Disrupted-In-Schizophrenia-1 (DISC1): neurodevelopment, cognition, and mental conditions | Q36517223 | ||
| Comorbid schizophrenia and substance abuse: a review of epidemiology and course | Q36590947 | ||
| Role of DISC1 in neural development and schizophrenia | Q36720430 | ||
| A proteomic approach to receptor signaling: molecular mechanisms and therapeutic implications derived from discovery of the dopamine D2 receptor signalplex. | Q36896270 | ||
| The role of GSK-3 in synaptic plasticity. | Q37098587 | ||
| Neuregulin 1-erbB4 pathway in schizophrenia: From genes to an interactome | Q37309811 | ||
| Methamphetamine treatment causes delayed decrease in novelty-induced locomotor activity in mice | Q37318253 | ||
| Molecular mechanisms of psychostimulant-induced structural plasticity | Q37325137 | ||
| Brain stress systems in the amygdala and addiction | Q37415172 | ||
| Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade | Q37416273 | ||
| What have the genomics ever done for the psychoses? | Q37612075 | ||
| GSK3 signalling in neural development | Q37774552 | ||
| The role of neurexins in schizophrenia and autistic spectrum disorder. | Q37832009 | ||
| Mice lacking the schizophrenia-associated protein FEZ1 manifest hyperactivity and enhanced responsiveness to psychostimulants | Q38289065 | ||
| Effects of chemical stimulation of the mesolimbic dopamine system upon locomotor activity | Q39082676 | ||
| Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis | Q39740702 | ||
| A glycogen synthase kinase 3-beta promoter gene single nucleotide polymorphism is associated with age at onset and response to total sleep deprivation in bipolar depression | Q40485025 | ||
| Drugs of abuse: biochemical surrogates of specific aspects of natural reward? | Q40623055 | ||
| Genomic structure and localisation within a linkage hotspot of Disrupted In Schizophrenia 1, a gene disrupted by a translocation segregating with schizophrenia. | Q40810638 | ||
| Dysfunction of dopamine release in the prefrontal cortex of dysbindin deficient sandy mice: an in vivo microdialysis study | Q42465222 | ||
| Ethanol-induced behavioral sensitization is associated with dopamine receptor changes in the mouse olfactory tubercle | Q42596087 | ||
| Enhanced dopamine function in DISC1-L100P mutant mice: implications for schizophrenia | Q42974942 | ||
| Substance use disorders in schizophrenia--clinical implications of comorbidity | Q43145195 | ||
| Escalating dose methamphetamine pretreatment alters the behavioral and neurochemical profiles associated with exposure to a high-dose methamphetamine binge | Q43848498 | ||
| Neurotoxic methamphetamine regimen severely impairs recognition memory in rats. | Q44436827 | ||
| Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis | Q44691029 | ||
| High-dose methamphetamine acutely activates the striatonigral pathway to increase striatal glutamate and mediate long-term dopamine toxicity. | Q45188930 | ||
| Plasticity of reward neurocircuitry and the 'dark side' of drug addiction | Q46177203 | ||
| Medial prefrontal cortex and nucleus accumbens core are involved in retrieval of the methamphetamine-associated memory | Q46414673 | ||
| Behavioral phenotypes of Disc1 missense mutations in mice | Q48178658 | ||
| Reductions in binding and functions of D2 dopamine receptors in the rat ventral striatum during amphetamine sensitization | Q48266835 | ||
| In vitro and ex vivo autoradiographic studies of nicotinic acetylcholine receptors using [18F]fluoronochloroepibatidine in rodent and human brain | Q48404297 | ||
| Impact of the DISC1 Ser704Cys polymorphism on risk for major depression, brain morphology and ERK signaling | Q48426188 | ||
| Association between GSK-3beta -50T/C polymorphism and personality and psychotic symptoms in mood disorders | Q48452728 | ||
| Alteration in kinase activity but not in protein levels of protein kinase B and glycogen synthase kinase-3beta in ventral prefrontal cortex of depressed suicide victims | Q48459918 | ||
| Characterization of dopamine-dependent rewarding and locomotor stimulant effects of intravenously-administered methylphenidate in rats | Q48510211 | ||
| Imaging the brain marijuana receptor: development of a radioligand that binds to cannabinoid CB1 receptors in vivo. | Q48568603 | ||
| Disability Income, Cocaine Use, and Repeated Hospitalization among Schizophrenic Cocaine Abusers — A Government-Sponsored Revolving Door? | Q51594247 | ||
| Inducible expression of mutant human DISC1 in mice is associated with brain and behavioral abnormalities reminiscent of schizophrenia. | Q51738410 | ||
| Repeated exposures intensify rather than diminish the rewarding effects of amphetamine, morphine, and cocaine. | Q51761695 | ||
| A haplotype within the DISC1 gene is associated with visual memory functions in families with a high density of schizophrenia. | Q51989526 | ||
| Substance use in a population-based clinic sample of people with first-episode psychosis | Q57773718 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 3 | |
| P921 | main subject | comorbidity | Q1414874 |
| P304 | page(s) | 1242-1251 | |
| P577 | publication date | 2011-02-17 | |
| P1433 | published in | Neuropharmacology | Q15332439 |
| P1476 | title | Mutant DISC1 affects methamphetamine-induced sensitization and conditioned place preference: a comorbidity model | |
| P478 | volume | 62 |
| Q37347747 | Abnormal context-reward associations in an immune-mediated neurodevelopmental mouse model with relevance to schizophrenia |
| Q30367009 | Animal models of gene-environment interaction in schizophrenia: A dimensional perspective. |
| Q30453396 | BDNF deficiency and young-adult methamphetamine induce sex-specific effects on prepulse inhibition regulation. |
| Q35505900 | Beyond cAMP: The Regulation of Akt and GSK3 by Dopamine Receptors |
| Q30413272 | Chronic exposure of mutant DISC1 mice to lead produces sex-dependent abnormalities consistent with schizophrenia and related mental disorders: a gene-environment interaction study |
| Q36634401 | DISC1 genetics, biology and psychiatric illness |
| Q39019384 | DISC1 signaling in cocaine addiction: Towards molecular mechanisms of co-morbidity. |
| Q37061724 | DISC1-ATF4 transcriptional repression complex: dual regulation of the cAMP-PDE4 cascade by DISC1. |
| Q28393891 | DISC1: Structure, Function, and Therapeutic Potential for Major Mental Illness |
| Q37331053 | Disrupted-in-schizophrenia1 (DISC1) L100P mutation alters synaptic transmission and plasticity in the hippocampus and causes recognition memory deficits |
| Q48877081 | Dominant negative DISC1 mutant mice display specific social behaviour deficits and aberration in BDNF and cannabinoid receptor expression |
| Q36254196 | Dopamine D2 receptor-mediated Akt/PKB signalling: initiation by the D2S receptor and role in quinpirole-induced behavioural activation |
| Q47572745 | Effects of genetic and environmental risk for schizophrenia on hippocampal activity and psychosis-like behavior in mice |
| Q48373242 | Immunization with DISC1 protein in an animal model of ADHD influences behavior and excitatory amino acids in prefrontal cortex and striatum. |
| Q30826347 | Misassembly of full-length Disrupted-in-Schizophrenia 1 protein is linked to altered dopamine homeostasis and behavioral deficits. |
| Q48288043 | Orexin A-mediated AKT signaling in the dentate gyrus contributes to the acquisition, expression and reinstatement of morphine-induced conditioned place preference |
| Q48898824 | Phentermine induces conditioned rewarding effects via activation of the PI3K/Akt signaling pathway in the nucleus accumbens |
| Q37633236 | The impact of Disrupted-in-Schizophrenia 1 (DISC1) on the dopaminergic system: a systematic review. |
| Q60800989 | mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders |
Search more.